Literature DB >> 12749290

Cyclooxygenase-2 mediates mucin secretion from epithelial cells of lipopolysaccharide-treated canine gallbladder.

Hong-Ja Kim1, Sung-Koo Lee, Myung-Hwan Kim, Dong-Wan Seo, Young-Ii Min.   

Abstract

Biliary mucin was regarded as a major contributing factor in formation of pigment stones as well as cholesterol ones. The aim of this study was to elucidate the mechanism of biliary mucin secretion in canine gallbladder epithelial (CGBE) cells treated by lipopolysaccharides (LPS) with special reference to cyclooxygenase (COX) -2. Confluent CGBE cells were incubated with following compounds for 8, 12, and 24 hr: (1) serum-free medium, (2) serum-free medium containing LPS (100 microm/ml), (3) serum-free medium containing LPS (100 microm/ml) with NS-398 (10 microM), and (4) serum-free medium containing LPS (100 microm/ml) with indomethacin (10 microM). Mucin assay and western blots for COX-1 and COX-2 were performed. Production of PGE2, and cAMP was also measured. Mucin secretion increased with time. At 12 hr, mucin secretion increased to 200% of control (from 100 +/- 5 to 200 +/- 45%, P < 0.05). LPS treatment significantly stimulated the COX-2 expression (P < 0.05). The productions of PGE2 and cAMP were increased from 299 +/- 68 to 524 +/- 163 pg/mg (P < 0.05) and from 0.2 +/- 0.1 to 0.92 +/- 0.4 pmol/ml (P < 0.05), respectively. NS-398, which completely inhibited COX-2 expression, significantly suppressed the level of PGE2 and cAMP as well as mucin secretion (P < 0.05). Indomethacin, which partially inhibited COX-2 expression, suppressed the production of PGE2, but not cAMP and mucin secretion. In conclusion, our results suggested that the PGE2 induced by COX-2 might play a role in mucin secretion from the gallbladder epithelium through the increment of cAMP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749290     DOI: 10.1023/a:1022832608466

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  In vivo and in vitro expression of a non-mammalian cyclooxygenase-1.

Authors:  D W Reed; W S Bradshaw; W Xie; D L Simmons
Journal:  Prostaglandins       Date:  1996-10

2.  Regulation of mucin secretion in human gallbladder epithelial cells: predominant role of calcium and protein kinase C.

Authors:  N Dray-Charier; A Paul; L Combettes; M Bouin; M Mergey; P Balladur; J Capeau; C Housset
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

3.  Lipopolysaccharide from Escherichia coli stimulates mucin secretion by cultured dog gallbladder epithelial cells.

Authors:  J Choi; J H Klinkspoor; T Yoshida; S P Lee
Journal:  Hepatology       Date:  1999-05       Impact factor: 17.425

4.  Regulation of fibroblast cyclooxygenase synthesis by interleukin-1.

Authors:  A Raz; A Wyche; N Siegel; P Needleman
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

Review 5.  Hepatolithiasis: present status.

Authors:  F Nakayama; A Koga
Journal:  World J Surg       Date:  1984-02       Impact factor: 3.352

Review 6.  Cyclooxygenase in biology and disease.

Authors:  R N Dubois; S B Abramson; L Crofford; R A Gupta; L S Simon; L B Van De Putte; P E Lipsky
Journal:  FASEB J       Date:  1998-09       Impact factor: 5.191

Review 7.  Primary intrahepatic stones.

Authors:  M H Kim; J Sekijima; S P Lee
Journal:  Am J Gastroenterol       Date:  1995-04       Impact factor: 10.864

8.  Evidence for a potent nucleating factor in the gallbladder bile of patients with cholesterol gallstones.

Authors:  M J Burnstein; R G Ilson; C N Petrunka; R D Taylor; S M Strasberg
Journal:  Gastroenterology       Date:  1983-10       Impact factor: 22.682

9.  Bile infection documented as initial event in the pathogenesis of brown pigment biliary stones.

Authors:  F M Cetta
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

10.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

View more
  5 in total

1.  T-cell function is critical for murine cholesterol gallstone formation.

Authors:  Kirk J Maurer; Varada P Rao; Zhongming Ge; Arlin B Rogers; Trisha J Oura; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2007-10       Impact factor: 22.682

Review 2.  Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review.

Authors:  Sreedevi Koppisetti; Bharat Jenigiri; M Pilar Terron; Sandra Tengattini; Hiroshi Tamura; Luis J Flores; Dun-Xian Tan; Russel J Reiter
Journal:  Dig Dis Sci       Date:  2008-03-13       Impact factor: 3.199

3.  Biliary Cast Syndrome: Hepatic Artery Resistance Index, Pathological Changes, Morphology and Endoscopic Therapy.

Authors:  Hu Tian; Qian-De Liao; Nian-Feng Li; Jian Peng; Lian-Sheng Gong; Ju Liu
Journal:  Chin Med J (Engl)       Date:  2015-07-20       Impact factor: 2.628

4.  Chronic DON exposure and acute LPS challenge: effects on porcine liver morphology and function.

Authors:  Lydia Renner; Stefan Kahlert; Tanja Tesch; Erik Bannert; Jana Frahm; Anikó Barta-Böszörményi; Jeannette Kluess; Susanne Kersten; Peter Schönfeld; Hermann-Josef Rothkötter; Sven Dänicke
Journal:  Mycotoxin Res       Date:  2017-05-04       Impact factor: 3.833

5.  Entamoeba histolytica Cysteine Proteinase 5 Evokes Mucin Exocytosis from Colonic Goblet Cells via αvβ3 Integrin.

Authors:  Steve Cornick; France Moreau; Kris Chadee
Journal:  PLoS Pathog       Date:  2016-04-13       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.